GlobeNewswire 2017-12-06 FDA Accepts New Drug Application (NDA) for Buprenorphine Sublingual Spray from INSYS Therapeutics
GlobeNewswire 2017-11-27 INSYS Therapeutics, Inc. to Participate in the 29th Annual Piper Jaffray Healthcare Conference
GlobeNewswire 2017-11-02 INSYS Therapeutics Reports Third Quarter 2017 Results
GlobeNewswire 2017-10-31 Nasdaq Scheduled Resumption in INSYS Therapeutics, Inc.
GlobeNewswire 2017-10-30 INSYS Therapeutics Provides Update on NASDAQ Trading Hold
GlobeNewswire 2017-10-30 INSYS Therapeutics to Record a Minimum Liability for Department of Justice Settlement in Q3 2017
GlobeNewswire 2017-10-30 INSYS Therapeutics Affirms Its Commitment to Sustainable Future Growth
GlobeNewswire 2017-10-30 INSYS Therapeutics Announces Resignation of Patrick P. Fourteau from Board of Directors
GlobeNewswire 2017-10-29 INSYS Therapeutics Founder Dr. John N. Kapoor Steps Down from Board of Directors
GlobeNewswire 2017-10-26 Nasdaq Halts INSYS Therapeutics, Inc.
GlobeNewswire 2017-10-19 INSYS Therapeutics to Report Third Quarter 2017 Results on Nov. 2
GlobeNewswire 2017-10-18 Depomed Announces Appointment of Santosh J. Vetticaden, M.D., PH.D. as Senior Vice President, Chief ...
GlobeNewswire 2017-10-09 INSYS Therapeutics, Inc. to Participate in Oppenheimer Specialty Pharma Summit
GlobeNewswire 2017-10-09 INSYS Therapeutics Extends ‘Compassionate Use’ Studies of Cannabidiol (CBD) for Refractory Pediatric...
GlobeNewswire 2017-10-06 INSYS Therapeutics Addresses New Jersey Complaint
GlobeNewswire 2017-10-03 INSYS Therapeutics Completes Pharmacokinetics (PK) Study of Intranasal Naloxone for Opioid Overdose
GlobeNewswire 2017-09-29 INSYS Therapeutics Files New Drug Application (NDA) for Buprenorphine Sublingual Spray with FDA
GlobeNewswire 2017-09-22 INSYS Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
GlobeNewswire 2017-09-21 INSYS Therapeutics Hires First Corporate Communications Leader and New Investor Relations Agency
GlobeNewswire 2017-09-01 Insys Addresses Arizona Attorney General Complaint
GlobeNewswire 2017-08-22 Insys Addresses Questions Raised by Illinois Settlement
GlobeNewswire 2017-08-03 Insys Therapeutics Reports Second Quarter 2017 Results
GlobeNewswire 2017-07-31 Insys Announces Availability of SYNDROS, the First and Only FDA-Approved Liquid Dronabinol, by Presc...
GlobeNewswire 2017-07-20 Insys Therapeutics to Report Second Quarter 2017 Results on August 3, 2017
GlobeNewswire 2017-07-18 Insys Therapeutics, Inc. Appoints Andrew G. Long as Chief Financial Officer